CHGCF - Chugai Pharmaceutical Co. Ltd. (CHGCF) CEO Osamu Okuda on Q3 2021 Results - Earnings Call Transcript

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2021 Earnings Conference Call October 22, 2021 5:00 AM ET Company Participants Osamu Okuda - President & Chief Executive Officer Toshiaki Itagaki - Executive Vice President & Chief Financial Officer Tetsuya Yamaguchi - Senior Vice President, Head of Project & Lifecycle Management Unit Shinji Hidaka - Vice President and Head of Marketing & Sales Division Junichi Nezu - Vice President, Head of R&D Portfolio Management Conference Call Participants Motoya Kohtani - Nomura Securities Seiji Wakao - JPMorgan Kazuaki Hashiguchi - Daiwa Securities Shinichiro Muraoka - Morgan Stanley Hidemaru Yamaguchi - Citi Securities Fumiyoshi Sakai - Credit Suisse Securities Presentation Operator I am Osamu Okuda, President and CEO of Chugai Pharmaceutical Company. I will give you the overview of the Third Quarter of Fiscal 2021. Please take a look at Slide 5. Revenues totaled ¥677.5 billion, for the period of January to September, up 17.5%

For further details see:

Chugai Pharmaceutical Co., Ltd. (CHGCF) CEO Osamu Okuda on Q3 2021 Results - Earnings Call Transcript